Glycine and Magnesium+Thiamine for the Treatment of Primary Ciliary Dyskinesia — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Glycine and Magnesium+Thiamine for the Treatment of Primary Ciliary Dyskinesia — Stella

Home/Primary Ciliary Dyskinesia/

View on ClinicalTrials.gov

Recruiting

Back to Primary Ciliary Dyskinesia trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Mexico

Instituto Nacional de Enfermedades Respiratorias, Mexico City

Key details

Sponsor

Instituto Nacional de Enfermedades Respiratorias

Enrollment target

~60 participants

Started

October 2025

Primary completion

March 2028

Age range

5 Years and older

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.